Perhaps the strongest molecular evidence for antigen selection in CLL emerged from the observation that a large proportion of CLL patients carry (quasi)identical, otherwise termed stereotyped, BcR IG (12). This evidence concerns the gene BCR and B-cell chronic lymphocytic leukemia.